Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions in China and internationally. The company offers various products, including patient monitoring, ultrasound, radiology, AED, defibrillation system, anesthesia, CLIA, chemistry, hematology, ventilators, electrocardiograph, endoscope camera system, operating tables, surgical lights, medical supply units, acces… Read more
Market Cap & Net Worth: Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760)
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (SHE:300760) has a market capitalization of $29.29 Billion (CN¥214.91 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #1424 globally and #57 in its home market, demonstrating a -2.27% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's stock price CN¥177.25 by its total outstanding shares 1212441394 (1.21 Billion).
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A Market Cap History: 2018 to 2026
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's market capitalization history from 2018 to 2026. Data shows growth from $16.55 Billion to $29.29 Billion (14.61% CAGR).
Index Memberships
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ChiNext
CNT
|
$643.66 Billion | 1.95% | #9 of 100 |
|
FTSE China A50
FTXIN9
|
$525.16 Billion | 2.39% | #14 of 50 |
Weight: Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.15x
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's market cap is 1.15 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
3.61x
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's market cap is 3.61 times its annual earnings
1.97x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $16.55 Billion | $13.75 Billion | $3.72 Billion | 1.20x | 4.45x |
| 2019 | $27.76 Billion | $16.56 Billion | $4.68 Billion | 1.68x | 5.93x |
| 2020 | $65.37 Billion | $21.03 Billion | $6.66 Billion | 3.11x | 9.82x |
| 2021 | $58.73 Billion | $25.27 Billion | $8.00 Billion | 2.32x | 7.34x |
| 2022 | $49.30 Billion | $30.37 Billion | $9.61 Billion | 1.62x | 5.13x |
| 2023 | $46.70 Billion | $34.93 Billion | $11.58 Billion | 1.34x | 4.03x |
| 2024 | $42.14 Billion | $36.73 Billion | $11.67 Billion | 1.15x | 3.61x |
Competitor Companies of 300760 by Market Capitalization
Companies near Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A in the global market cap rankings as of March 18, 2026.
Key companies related to Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A Historical Marketcap From 2018 to 2026
Between 2018 and today, Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's market cap moved from $16.55 Billion to $ 29.29 Billion, with a yearly change of 14.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥29.29 Billion | -6.93% |
| 2025 | CN¥31.47 Billion | -25.31% |
| 2024 | CN¥42.14 Billion | -9.76% |
| 2023 | CN¥46.70 Billion | -5.29% |
| 2022 | CN¥49.30 Billion | -16.05% |
| 2021 | CN¥58.73 Billion | -10.16% |
| 2020 | CN¥65.37 Billion | +135.51% |
| 2019 | CN¥27.76 Billion | +67.68% |
| 2018 | CN¥16.55 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $29.29 Billion USD |
| MoneyControl | $29.29 Billion USD |
| MarketWatch | $29.29 Billion USD |
| marketcap.company | $29.29 Billion USD |
| Reuters | $29.29 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.